Cytek Biosciences (CTKB) Work In Process (2020 - 2026)

Cytek Biosciences' Work In Process history runs 7 years deep, the most recent figure standing at $16.3 million for Q1 2026.

• Quarterly Work In Process rose 155.62% year-over-year to $16.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (up 155.62% YoY) and the FY2025 annual result came in at $16.5 million, up 154.79% from the prior year.
• Work In Process was $16.3 million for Q1 2026 at Cytek Biosciences, down from $16.5 million in the prior quarter.
• Across five years, Work In Process topped out at $16.5 million in Q4 2025 and bottomed at $1.5 million in Q1 2022.
• A 5-year average of $7.4 million and a median of $6.3 million in 2024 frame the typical range for Work In Process.
• Annual changes were most pronounced in 2023 — Work In Process jumped 201.39% — and 2024, when it slumped 48.56%.
• Cytek Biosciences' Work In Process stood at $4.9 million in 2022, then jumped by 113.48% to $10.5 million in 2023, then slumped by 37.94% to $6.5 million in 2024, then jumped by 154.79% to $16.5 million in 2025, then slipped by 1.16% to $16.3 million in 2026.
• Business Quant data shows CTKB's Work In Process at $16.3 million in Q1 2026, $16.5 million in Q4 2025, and $6.7 million in Q3 2025.